Home/Companies/Biotech/ReproNovo

ReproNovo

Biotech·

France·Active·2yr hold

Entry

2024

Hold

2yr

Status

Active

Who owns ReproNovo?

ReproNovo is a French Biotech company, currently owned by ALSA Ventures since 2025 and 2 other investors.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY

Most recent investor

Jeito Capital

Jeito II · 2026 · VC

3 ownership periods · full history below

Key facts

HQFrance

SectorBiotech

Ownership history

3 ownership periods · co-invest detected

Active

Co-held by Jeito Capital, ALSA Ventures and Ysios Capital Partners since 2024.

Co-invest · 3 holders · 2024 · present

Jeito CapitalActive

2024 · present(2yr) · Jeito II · 2026 · VC

Ysios Capital PartnersActive

2025 · present(1yr) · Ysios BioFund III · 2020 · Life Sciences VC

ALSA VenturesActive

2025 · present(1yr) · ALSA Ventures European Biotechnology Fund · 2020 · Life Sciences VC

More from Jeito II

Other portfolio companies in the same fund.

Augustine Therapeutics

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare

Active

The Carlyle GroupChina

Adagene

Active

General AtlanticChina

Advanced Cell Diagnostics

Questions

Who owns ReproNovo?

ReproNovo is currently owned by ALSA Ventures, Ysios Capital Partners and 1 other, through Jeito II, since 2025.

When did ALSA Ventures and 2 others acquire ReproNovo?

ALSA Ventures and 2 others acquired ReproNovo in 2025.

Who has owned ReproNovo over time?

ReproNovo has been through 3 private-equity ownership periods: Jeito Capital · via Jeito II · since 2024; ALSA Ventures · via ALSA Ventures European Biotechnology Fund · since 2025; Ysios Capital Partners · via Ysios BioFund III · since 2025.

Look up another firm or company

Data refreshed weekly · Sourced from public filings · Report an issue